cagrisema cagrilintide semaglutide phase 3 results 2024 2025 obesity drug: what the data shows Novo Nordisk's CagriSema outperforms Ozempic
Description
doi: 10.3181/00379727-100-24576
Inspect the injection site to ensure it is clear of bruising, swelling, irritation or hardness
This can occur due to loss of appetite, digestive issues, and muscle weakness, which are common side effects of B12 deficiency
doi: 10.1016/S0924-977X(01)00076-1
Pooling the data allowed for a broader range of serum levels, more data, and thus improved statistical power
